We advised Verman as lead counsel in the cross-border acquisition of Biosym A/S, Boma Lecitin GmbH and Nordic Nutraceuticals UK Ltd (together “Biosym Group”) with support from local counsels in Denmark, the United Kingdom, Germany and Sweden. The transaction was closed on 6 May 2019.
Verman, founded in 1987, is one of the fastest growing pharmaceutical companies in Finland, with market leading products in several product categories.
Bisosym, founded in 1986, is headquartered in Denmark and specialises in the development and manufacture of vitamins, minerals, 3-6-7-9 Omega fatty acids, lactic acid bacteria, herbal preparations and other nutrients. Prior to the transaction, Biosym Group was owned by its founder Kim Nielsen.